代谢综合征患者的心外膜脂肪:系统综述与荟萃分析
该系统综述与荟萃分析检索2000年1月1日至2022年10月31日电子数据库,比较代谢综合征与非代谢综合征者的心外膜脂肪体积(CT测量)和厚度。代谢综合征患者心外膜脂肪体积(SMD 1.07,95%CI 0.69-1.45,p<0.001)和厚度(SMD 1.12,95%CI 0.84-1.41,p<0.001)均显著增加;结论认为代谢综合征患者右心室游离壁附近心外膜脂肪厚度及总心外膜脂肪体积更大,心外膜脂肪作为影像生物标志物独立影响代谢综合征的发生。
要点
- 代谢综合征患者CT测得心外膜脂肪体积较非代谢综合征者显著增高(SMD 1.07,95%CI 0.69-1.45,p<0.001)。
- 代谢综合征患者心外膜脂肪厚度较非代谢综合征者显著增大(SMD 1.12,95%CI 0.84-1.41,p<0.001)。
- 心外膜脂肪厚度在高加索与美洲亚组大于亚洲与非洲亚组(SMD 1.32,95%CI 0.44-2.20,p<0.001),青少年与成人或老年亚组间也有显著SMD(1.21,95%CI 0.84-1.52,p<0.001)。
核心结论
- 代谢综合征患者倾向于在右心室游离壁附近出现更大的心外膜脂肪厚度和更大的总心外膜脂肪体积;心外膜脂肪作为影像生物标志物独立影响代谢综合征的发生。
研究设计与样本
- 系统综述与荟萃分析,检索2000年1月1日至2022年10月31日电子数据库,由两名研究者独立检索;纳入两种心外膜脂肪量化指标:基于CT的总心外膜脂肪体积和心外膜脂肪厚度,比较代谢综合征组与非代谢综合征组,采用随机效应模型估计标准化均数差(SMD)及95%置信区间;通过荟萃回归和亚组分析探索异质性。
诊断标准与关键数值
- 心外膜脂肪体积:代谢综合征组较非代谢综合征组显著增高,SMD 1.07(95%CI 0.69-1.45,p<0.001)。
- 心外膜脂肪厚度:代谢综合征组较非代谢综合征组显著增大,SMD 1.12(95%CI 0.84-1.41,p<0.001)。
- 心外膜脂肪厚度亚组比较:高加索与美洲亚组大于亚洲与非洲亚组,SMD 1.32(95%CI 0.44-2.20,p<0.001)。
- 心外膜脂肪厚度年龄亚组比较:青少年与成人或老年个体间存在显著SMD 1.21(95%CI 0.84-1.52,p<0.001)。
临床应用与阅片要点
- 作者结论认为代谢综合征患者倾向于右心室游离壁附近心外膜脂肪厚度更大及总心外膜脂肪体积更大。
- 作者结论认为心外膜脂肪作为影像生物标志物独立影响代谢综合征的发生。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Abnormally increased epicardial fat appears to be associated with an additional risk of major adverse cardiovascular events (MACEs) in the context of metabolic syndrome (MetS). However, evidence on the relationship between epicardial fat volumes (EFVs), epicardial fat thickness (EFT) and MetS remains inconsistent.
METHODS: Specific searches of electronic databases from 1 January 2000 to 31 October 2022 were independently performed by two researchers. In this study, two quantification measures of epicardial fat were included: comparison of total computed tomography-based EFVs and EFT between two groups (individuals with and without MetS), estimating standardized mean difference (SMD) with corresponding 95 % confidence intervals (CIs) through a random-effects model analysis. The heterogeneity in the included studies was explored by meta-regression and subgroup analyses.
RESULTS: The EFVs were significantly increased in MetS subjects compared with non-MetS subjects (SMD: 1.07, 95 % CI: 0.69-1.45, p < 0.001), and the EFT was also significantly larger in MetS patients than in the Non-MetS (SMD: 1.12, 95 % CI: 0.84-1.41, p < 0.001). We compared the Caucasian and American subgroups with the Asian and African subgroups, and the EFT was greater in the former subgroups (SMD: 1.32, 95 % CI: 0.44-2.20, p < 0.001). When comparing the EFT among the age subgroups, there was a significant SMD between adolescents and adults or elderly individuals (SMD: 1.21, 95 % CI: 0.84-1.52, p < 0.001).
CONCLUSIONS: MetS patients tend to present greater EFT near the right ventricular free wall and greater total EFVs. Increased epicardial fat, an imaging biomarker, independently affects the onset of MetS.
引用
- Ma ZY, Duan H, Han D, et al. Epicardial fat in patients with metabolic syndrome: A systematic review and meta-analysis. Eur J Radiol. 2023. PMID: 37666076. doi:10.1016/j.ejrad.2023.111056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。